New Data Raise Concern About Medicare Quality Payment Program, Radiology Experts Say

Why It Matters

Capping topped‑out measures curtails Medicare’s leverage to drive continuous quality gains, especially in radiology, potentially raising future healthcare costs. The misalignment between measure design and clinician participation threatens reimbursement incentives and patient‑care outcomes.

Key Takeaways

• 49% of MIPS measures topped out by 2023.
• Median reporting rate only 7% across specialties.
• Diagnostic radiology reports 38% of its measures, highest among fields.
• 70% of specialties have over half of measures topped out.
• Premature measure removal may hinder quality improvement incentives.

Pulse Analysis

The Medicare Quality Payment Program (QPP) was introduced to reward clinicians for delivering high‑value care, using the Merit‑Based Incentive Payment System (MIPS) as its core engine. By linking reimbursement to performance on specialty‑specific measures, policymakers hoped to spur data‑driven improvements. However, the new study, which cross‑referenced QPP datasets with MIPS benchmarks, shows that almost half of the 275 measures have already reached their maximum scores, and most physicians submit data on only a fraction of available metrics. This saturation suggests that the current measure set may no longer differentiate performance effectively.

Radiology stakeholders are particularly affected. While diagnostic radiology boasts the highest reporting rate at 38%, it still falls short of broad participation, and the specialty sees 93% of its measures topped out. The American College of Radiology and Neiman Institute experts argue that capping these measures prematurely diminishes financial incentives for quality work and discourages investment in future metric development. For small imaging groups and solo radiologists, the loss of meaningful performance levers could translate into reduced Medicare reimbursements and increased operational uncertainty, potentially impacting patient access to advanced imaging services.

Policymakers face a choice: redesign the MIPS framework to introduce more granular, specialty‑aligned measures, or shift capping decisions to the clinician or practice level rather than applying blanket caps. Adding imaging‑focused metrics, as the ACR recommends, could restore relevance and encourage continuous improvement. In the longer term, a dynamic measure portfolio that evolves with clinical practice patterns will be essential to preserve the QPP’s credibility and to ensure that Medicare incentives remain aligned with real‑world quality outcomes.